Related by context. Frequent words. (Click for all words.) 64 Decapeptyl R 63 PLAVIX R 63 Paraplatin 62 Ixempra 62 Rebetol 62 USD #.#bln [001] 61 Sumatriptan 61 Actimmune R 61 Engerix B 61 Maxipime 60 plus prednisone 60 AMRIX 60 % lc 60 Xalatan 59 Wellbutrin SR 59 R exenatide injection 59 Epivir 59 comparedto 59 R sorafenib tablets 59 Gemzar ® 58 VANTAS 58 Generic Version 58 totaled SEK 58 Copaxone ® 58 BioMarin Genzyme LLC 58 3Q FY# 57 pegylated interferon alpha 57 Argatroban 57 ONTAK 57 Nabi HB 57 Zanaflex 57 unconsolidated joint 56 Novogyne 56 TPIAO 56 Interest Income Expense 56 Pfizer Sutent 56 Ps.2 56 Gabitril 56 Release Tablets 56 ARIMIDEX 56 CHF#.# [001] 56 CRINONE R 55 EBIT amounted 55 NET PROFIT 55 ALTANA Pharma 55 totaled MEUR 55 g h 55 RITUXAN 55 INTEGRILIN 55 XIENCE V demonstrated 55 TRISENOX 55 refractory chronic lymphocytic 55 PTOI 55 bendamustine 55 ZALBIN 55 anincrease 54 CIMZIA TM 54 Astelin 54 CRINONE ® 8 54 Turnover amounted 54 Operating Expenses Operating 54 Fully diluted EPS 54 Interest Expense Net 54 GVAX R 54 AVINZA 54 elotuzumab 54 Pro forma EBITDA 54 -DD2 53 neutropenia thrombocytopenia 53 Gross Profit Gross 53 Copaxone R 53 Noninterest expense decreased 53 USD#.#bn [002] 53 Eligard R 53 crore QoQ 53 Prescriptions filled 53 AZASITE 53 Enablex 52 Total Noninterest Expense 52 - Operating [016] 52 dacarbazine 52 EUR#.#bn [002] 52 #.#bn rub [003] 52 Segment EBIT 52 Clarinex 52 Sular 52 Lilly ICOS LLC 52 Q2 FY'# 52 Normalized EBITDA 52 Ps.4 52 JPY#.# billion [002] 52 metastatic hormone refractory 52 Chemicals Segment 52 Ranexa R 52 GMLAAM 52 NET REVENUES 52 excluding divestments 52 - - Total [053] 52 Q1 FY'# 52 GBP #.#m [003] 51 medicine Norvasc